BUPP DAVID C

CIK 00011957571 companyDUBLIN, OH

SEC Profile

Transactions

Companies

Filings

CIK

0001195757

Recent Transactions

50 trades

Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-12-19$2.54/sh−7,814→ 2,750,328 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-12-16$2.45/sh−42,186→ 2,758,142 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-11-21$2.19/sh−10,000→ 2,500,328 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-11-18$2.25/sh−6,100→ 2,510,328 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-11-17$2.27/sh−10,000→ 2,516,428 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-11-16$2.28/sh−23,900→ 2,526,428 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-10-17$2.89/sh−50,000→ 2,550,328 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-08-15+300,000→ 2,900,328 total
Gift
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-06-21−13,000→ 2,600,328 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-06-03$4.52/sh−234,000→ 2,613,328 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-06-02$4.74/sh−233,000→ 2,547,328 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-06-01$5.00/sh−233,000→ 2,780,328 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-05-27$0.32/sh+450,000→ 2,693,328 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-05-27$0.31/sh+320,000→ 3,013,328 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
Warrant -Right to Buy
2011-05-27−20,000→ 0 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-05-27+20,000→ 213,746 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
Warrant -Right to Buy
2011-05-27−450,000→ 0 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
Warrant -Right to Buy
2011-05-27−320,000→ 0 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-15+400,000→ 2,243,328 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-15+300,000→ 2,543,328 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.36/sh+200,000→ 1,655,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.14/sh+100,000→ 2,410,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−300,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−200,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.42/sh+180,000→ 2,035,649 total
Tax Payment
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.32/sh−637,321→ 1,843,328 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.27/sh+300,000→ 1,255,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.39/sh+200,000→ 1,455,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.26/sh+200,000→ 1,855,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.49/sh+150,000→ 2,185,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.30/sh+125,000→ 2,310,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−200,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−180,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−125,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−100,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−70,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−150,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2011-04-13−200,000→ 0 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2011-04-13$0.13/sh+70,000→ 2,480,649 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-11-15$1.76/sh+10,000→ 990,649 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-11-15$1.77/sh+5,000→ 995,649 total
Will/Inheritance
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-11-01−40,000→ 940,649 total
Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
10% Convertible Note Due 07/08/08
2010-06-24$0.31/sh−3,225,806→ 0 total
Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
8% Convertible Preferred Stock
2010-06-24+1,613,000→ 1,613,000 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2010-06-17$0.41/sh−90,000→ 0 total
Gift
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-06-17−30,000→ 980,649 total
Exercise/Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-06-17$0.41/sh+90,000→ 1,010,649 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-05-03$1.81/sh+7,400→ 914,569 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-05-03$1.82/sh+6,080→ 920,649 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2010-05-03$1.80/sh+16,520→ 907,169 total

Companies

NAVIDEA BIOPHARMACEUTICALS, INC.
Director, CEO and President

Recent Filings

Address

425 METRO PLACE NORTH SUITE 300

DUBLIN, OH, 43017

View on SEC.gov